Results 231 to 240 of about 30,053 (265)

Safety and efficacy of tolvaptan in real‑world Japanese patients with autosomal dominant polycystic kidney disease: final results of SLOW‑PKD surveillance. [PDF]

Clin Exp Nephrol
Mochizuki T, Muto S, Suzue K, Komaniwa S, Tanaka T, Fukuta Y, Yamashige Y.   +6 more
europepmc   +1 more source

Pneumatocele Development after Deceased-Donor Liver Transplantation for Multiple Hepatic Cysts due to Autosomal Dominant Polycystic Kidney Disease: A Case Report. [PDF]

Surg Case Rep
Yoshiyama A, Kawashima M, Nagata S, Fukushima T, Aze K, Cong Y, Nakao K, Nakao M, Toyokawa G, Konoeda C, Hasegawa K, Sato M.   +11 more
europepmc   +1 more source

Gut microbiota and kidney function in autosomal dominant polycystic kidney disease participants in Cameroon: a cross-sectional study. [PDF]

BMC Nephrol
Obolo Nwaga I, Nzana VB, Bughe RN, Dah I, Cho-Fon C, Mahamat M, Ndjong E, Nono A, Mballa JC, Acho FA, Moor VA, Mbacham WF, Kaze FF.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Autosomal Dominant Polycystic Kidney Disease

Primary Care: Clinics in Office Practice, 2020
Autosomal Dominant Polycystic Kidney Disease is an inherited multisystemic disorder of the renal tubules with subsequent formation of multiple cysts and enlargement of the kidney, affecting various organs. Diagnosis is initially suspected in those with family history and/or individuals who develop hypertension early on (secondary hypertension) or ...
Parvathi Perumareddi, Darin P. Trelka
openaire   +4 more sources

Autosomal dominant polycystic kidney disease

The Lancet, 2007
Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. It is associated with large interfamilial and intrafamilial variability, which can be explained to a large extent by its genetic heterogeneity and modifier genes.
Vicente E. Torres, Peter C. Harris, Yves Pirson   +2 more
openaire   +3 more sources

Autosomal Dominant Polycystic Kidney Disease

New England Journal of Medicine, 1990
Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disease occurring in 1 in 200 to 1 in 1,000 individuals. ADPKD is characterized by cystic lesions in the kidneys and often by structural abnormalities in the gastrointestinal tract and cardiovascular system.
openaire   +5 more sources

Autosomal dominant polycystic kidney disease

BMJ, 2016
#### What you need to know Polycystic kidney disease (PKD) is an inherited condition defined by the pathological development of fluid-filled cysts throughout the kidneys leading to organ enlargement (fig 1⇓) and chronic kidney disease. Autosomal dominant polycystic kidney disease (ADPKD) is the commonest inherited kidney disease1 and is the fourth ...
openaire   +3 more sources

Angiogenesis and autosomal dominant polycystic kidney disease

Pediatric Nephrology, 2012
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the growth of multiple cysts that in many cases result in end-stage renal disease. Current strategies to reduce cyst progression in ADPKD focus on modulating cell turnover, fluid secretion, and vasopressin signalling; but an alternative approach may be to target pathways providing
Huang, JL, Woolf, AS, Long, DA
openaire   +4 more sources